A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.

Breitbart, W; Marotta, R; Platt, M M; Weisman, H; Derevenco, M; Grau, C; Corbera, K; Raymond, S; Lund, S; Jacobson, P

Breitbart, W; Marotta, R; Platt, M M; Weisman, H; Derevenco, M; Grau, C; Corbera, K; Raymond, S; Lund, S; Jacobson, P.

Affiliation

Breitbart W; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Am J Psychiatry ; 153(2): 231-7, 1996 Feb.

Article in En | MEDLINE | ID: mdl-8561204

Subject(s)

AIDS Dementia Complex/drug therapy; Chlorpromazine/therapeutic use; Delirium/drug therapy; Haloperidol/therapeutic use; Hospitalization; Lorazepam/therapeutic use; AIDS Dementia Complex/diagnosis; Adult; Basal Ganglia Diseases/chemically induced; Basal Ganglia Diseases/epidemiology; Chlorpromazine/adverse effects; Delirium/diagnosis; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol/adverse effects; Humans; Lorazepam/adverse effects; Male; Middle Aged; Prevalence; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Chlorpromazine / AIDS Dementia Complex / Delirium / Haloperidol / Hospitalization / Lorazepam Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Psychiatry Year: 1996 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links